Clinical Trial Update: A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessing the effects of atorvastatin on Graves' Orbitopathy is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Orbitopathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Pisa | Conditions: Graves' Orbitopathy | Phase 3 | Status: NOT_YET_RECRUITING